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Putative transmembrane helix 3 of the tetracycline/H + antiporter ncoded by a transposon, Tnl0, contains four serine residues, Set-77, Set.S2, Ser-91 
and Ser-92. Each of these scrine residues was replaced by site-directed mutagenesis. Of these four serine residues, Ser-77 was important for the 
transport function, and a bulky side chain at position 91 hindered substrate translocation, whereas 5¢r-82 and Ser-92 did not play any role. $er-77 
and S¢r-91 are on the same vertical stripe, that includes the essential Asp-84, on the hydrophilic side of putative helix 3. These observations suggest 
that helix 3 is part of the tetracycline translocation channel across the membrane. 
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1. INTRODUCTION 
The transposon Tnl0-encoded tetracycline r sistance 
protein (TnI0-TET) is a metal-tetracycline/H" an- 
tiporter [1]. TnI0-TET is a membrane protein [2] com- 
posed of 401 amino acid residues [3,4]. On the basis of 
its hydropathy profile, and the results of protease diges- 
tion and antibody binding, a topological model contain- 
ing 12 lransmembrane h lices and il interhelix loops 
was proposed (Fig. I) [5,6]. Although Tnl0-TET con- 
tains 43 charged residues, only four are located in the 
transmembrane h lix region. Of these transmembrane 
charged residues, Asp-84 is one of the essential residues 
for tetracycline translocation [7]. Asp-84 seems to play 
a role in substrate recognition in combination with Asp- 
15 and Asp-285 through their negative charges [7]. Asp- 
84 is located in putative helix 3 (Fig. 1). We also found 
that Asp-66, located in cytoplasmic Ioop.~_~ (Fig. l), is 
also essential for tetracycline transloeation, probably 
through a gating role [8]. Cytoplasmic loop.~_3 (Fig. 1) 
is connected with helix 3. Thus, helix 3 must be impor- 
tant as a route for substrate migration from a putative 
gate, loop,._~, to a proposed substrate recognition site, 
Asp-84. It is reasonable to expect hat some of the polar 
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residues in this route are involved in substrate translo- 
cation. 
Helix 3 contains four serine residues, of which Set-77 
and Ser-82 are located between loop.,_3 and Asp-84. 
Only Ser-77 is conserved in all TET proteins of Gram- 
negative bacteria so far sequenced belonging to classes 
A, B and C [9]. The other three serine residues are not 
conserved, however, site-directed replacement of these 
unconserved residues can provide a clue as to whether 
or not they are located in the substrate translocation 
route. In this study, each serine residue in helix 3 was 
replaced with a cysteine, alanine, or threonine by site- 
directed mutagenesis. 
2. MATERIALS AND METHODS 
2.1. Materials 
3 3~ [ H]Tetracyclinc and 5-g-[ SldCTP were purchased from Du Pont- 
New England Nuclear and Amersham. rgspeetivdy. All other materi- 
als were of reagent grade and obtained from commercial sources. 
2.2. Site-directed mutagenesis 
M utagenesis was l~rformed by the method of Taylor etal. l10] with 
an oligonueleotide-directed in vitro mutagenesis system (Version 2: 
Amersham) usin8 pER as a template as described in our previous 
paper [7]. The mutagenic primers (Table l) were synthesiz~ with an 
Applied Biosystems DNA synthesizer Model 380B or CYCLONE 
Plus DNA/RNA Synthesizer (MilliGen Biosearch Co.). Mutant genes 
were transferred to pLGT [8] by fragment exchange. 
2,3. Transport assays 
The inverted membrane vesicles were prepared from E. coti W3104 
[i 1] cells containing the wild-type or a mutant plasmid, as descrihed 
previously [12]. [~H]Tetracycline uptake by inverted membrane vesi- 
cles was assayed as described previously [8] in the presence of 50/aM 
CoCI.,, 10/aM [3H]tctraeycline and 2.5 mM NADH in MOPS-KOH 
buffer (pH 7.0) unless otherwise stated. 
Published by Elsevier Science Publishers B.V. 229 
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Fi~. 1. Secondary structure model or the helix 2-1oop,_,-helix 3 region 
or the TnI0.TET protein. Amino acid re~idue~ are depicted by one 
letter symbols. Hydrophobic domains are shown in boxes as trans. 
membrane ~.helices. Serine residues mutated inthe present work are 
depicted by bohl etters with the numbers of their position~ in the 
primary sequence. Essential residues tbr tetracycline transport, which 
have been found in our previous papers [7,8.12], are indicated by 
outlined letters. 
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Fig. 9. Immunoblot analysis of inverted membrane v sicles from E. 
coli W3104 cells harboring the wild-type or a mutant pla~mid. (A) 
Wild-type and Cys mutants: lane 1, wild-type; lane 2, no plasmid; lane 
3, $77C; lane 4, S82C; lane 5, $91C; lane 6, S92C. (B) Ala or Thr 
mutants: lane 1, $77A; lane 2, $77T; lane 3, SglA; lane 4, S91T. 
3. RESULTS AND DISCUSSION 
3.1. The effect of replacement of serine residues in helix 
3 with cysteine 
Four serine residues in helix 3 were replaced by a 
cysteine residue by oligonucleotide-directed site-specific 
mutagenesis. Inverted membrane vesicles prepared 
from E. coli W3104 carrying the mutant plasmids con. 
tained the normal amount of TET proteins detected by 
immunoblot analysis (Fig. 2A). 
As shown in Fig. 3, among the lout' Cys mutants, only 
the Cys-77 mutant vesicles had completely lost tetracy- 
cline transport activity. This finding is consistent with 
the fact that Ser-77 is the only conserved serine residue 
in helix 3 [9]. Of the three other Cys mutants, Cys-91 
showed a significant decrease in tetracycline transport 
(Fig. 3)° which was about 20% the wild-type activity 
(initial rate for 30 s). In contrast, the Cys-82 and Cys-92 
mutants howed similar activity to the wild-type (Fig. 
3). Therefore, it is concluded that Ser-82 and Ser-92 do 
not play a role in the TET function, whereas Ser-91 may 
have some relationship to the TET function. 
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3.2. Replacement of Ser-77 or Set.91 with alanine or 
threonine 
The volume of the side chain of a cysteine residue is 
about 1.5-times larger than that of serine [13], and is 
hydrophobic and shows weak hydrogen bonding. In 
order to reveal whether the defect in the activity of the 
Cys mutants is due to the steric hindrance or the massive 
side chain or to the lack or hydrogen bonding, Ser-77 
or Ser-91 were replaced by Thr or Ala. These mutations 
did not affect the expression of the TET protein (Fig. 
2B). 
The replacement of Ser-77 by Thr caused complete 
loss of activity (Fig. 4A) as did the replacement by Cys. 
However, the Ala-77 mutant showed unexpectedly high 
activity of about 45% the wild-type. Therefore, it is 
concluded that an hydroxyl group at position 77 is not 
obligatory for the tetracycline transport function. K,n 
values of the initial tetracycline uptake for 30 s were 
calculated from Lineweaver-Burk, Hanes-Woolf and 
Eadie plots. In any plot, the K,n value of the wild-type 
TET was 46/aM, which was higher than the previously 
reported Km value [8], probably due to the difference in 
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Fig. 3. Tetracycline (TC) uptake by inverted membrane vesicles from 
E, colt W3104 cells harboring the wild.type or Cys mutant plasmid, 
['~H]Tetracycline uptake was examined in the presence of 50/aM 
CoCIa. e, wild-type; m, S77C; A, $82C; &, 591 C; D, $92C, Open circles 
with broken line indicate the background uptake by the wild-tyr~ 
vesicles in the absence of NADH, 
the assay conditions. The K,, value of the Ala-77 mutant 
was about 100 pM. Thus, the affinity of the Ala-77 
mutant o tetracycline was clearly lower than that ofthe 
wild-type, indicating that an hydroxyl group at position 
77 contributes to the affinity for substrate binding. The 
complete loss of the activity in the Thr-77 mutant indi- 
cated that the strict arrangement of the hydroxyl group 
at position 77 is absolutely needed for its contribution 
to the activity. Since the Ala-77 mutant showed signifi- 
cant residual activity, the loss of activity in the Thr and 
Cys mutants eems to be due to the stcric hindrance o1' 
the massive side chain. 
On the other hand, the Thr-91 mutant showed a de- 
creased but significant activity similar to the Cys-91 
mutant, whcrcas the Ala-91 mutant showed normal ac- 
tivity, i.¢. similar to the wild-type, indicating that the 
hydroxyl group at position 91 did not contribute to the 
transport activity (Fig. 4B). Since the Thr-91 and Cys- 
91 mutants howed clearly lower activity than the wild- 
type and Ala mutant, the massive side chain at position 
91 is also likely to inhibit the tetracycline transport, 
however, the degree of strictness of the side chain ar- 
rangement at position 91 required for activity seems to 
be far less than that at position 77. 
Table I 
Mutagenie primers used Ibr site-directed mutagen~is, and codons changed in the mutant plasmids 
Plasmid Primer sequence Substituting residue 
Position Codon Amino acid 
. t~ ' *  
pS77C 5'- GTGCTGTTGTTGTGCCTAATAGGCGCATCG-  3' 77 TCA-gTGC Set~Cys 
Bgl I 
pS82C 5'- TTAATAGGCGCATGCCTGGATTACTTATTG-  3' 82 TCG-~TGC Scr~Cys 
SphI 
pS91C 5'-TTATTGCTGGCTTCTGCAGTGCGCTTTGG-3' 91 TTI'-~TTC Scr~Cys 
Pst I  
pS92C 5 - CTGGCTTTTTCATGCGCGCTTTGGATGCTG-  3' 92 AGT-~TGC $er~Cys 
BssHI I  
rm * pS77A 5 - GTGC ~ GTTGCTAGCGCTAATAGGC-  3 77 TCA- -~GCG Ser~Ala 
Eco47 I I I  
pS77T 5'- CGGAGGCCTGTGCTGTTGTTGACATTAAT-  3' 77 TCA-.--~ACA Ser-~Thr 
s~uI 
pS91A 5'- CTGGCTTTTGCTAGCGC TCTTTGS - 3' 91 TCA-~GCT Ser--~Ala 
Eco4TIII 
pS9 IT 5'-C'fGGCTTTTACAAGCGCTCTTTGG-3' 91 TCA-~,ACA Ser--~Thr 
Eco4711I 
The mutagenic primers contained two kinds of mismatches, mismatches tocause amino acid replacements (a terisks) and silent mismatches tocause 
new restriction site(s) (underlined). 
231 
Volume 307, number 2 FEBS LETTERS July 1992 
Q. 
2 
0 
(A) 
i' " • 
i ~TTI" no pno~y >i 
~O 60 90 120 
TIME (see) 
iii 
D I 
(B) 
~J  . " "  SmT no en~r~ly -~ i 
I III . "  . . . . . . . . . . . . .  KI..,z . . . . .  l I 
I ~.-~.. ,~-- .m- --u" i 
~ I I i l  
0 30  60 90 120 
TIMI~ (se~) 
Fi~. 4. Tetracycline uptake by inverted vesicles ¢ontainin8 a mutant TET protein of which Ser-77 or Ser.91 were substituted by Ala or Thr. The 
assay conditions were the same as in Fig. 3. (A) 5er-77-substitution mutants; e, $77A; II, $77T. Open squares with broken line indicate the 
background uptake by the S77T vesicles in the absence of NADH. (B) $ergl.substitution mutants; o, S91A; ,,, SglT. Open squar¢.~ with broken 
line indicate the background uptake by the SglT vesicles in the absence of NADH. 
3,3. Arrangements of  the set#re residues on the helical 
tvheel projection of the helix 3 
Fig. 5 shows a helical wheel projection of helix 3, in 
which the positions of the Asp and Ser residues, denoted 
as three letter symbols, in the primary sequence of 
TnI0-TET are shown. An arrow indicates the direction 
of the hydrophobic moment of this helix, calculated 
using Kyte and Doolittle's hydropathy index [13], indi- 
cating that helix 3 is amphipathic. Such amphiphilic 
helices have been widely reported in membrane proteins 
[14] and are expected to form a membrane-spanning 
channel structure [14], It is very interesting that the 
important serine residues, Set-77 and Set-91, are on a 
vertical stripe that includes another essential residue, 
Asp-84 [7], situated on the hydrophilie side of helix 3. 
Such a stripe-like arrangement of important residues 
has also been reported in [ac permease [15,16]. The 
results in this report also support the gating-channel 
model for transport [17]. 
Fig. 5. Helieatl-wheel projection of Asp and Ser residues in putative 
helix 3. Residues important for or related to tetracycline transport 
function are shown enclosed, The arrow indicates the direction of the 
hydrophobic moment o1" this helix, calculated using K2cte and Doolit- 
tle'~ hydropath2/indexes [13] for residues from Pro-72 to Met-96. 
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